跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“Elecsys pTau217”
全部
71
临床试验
18
药物
3
机构
1
资讯
49
2年前
FDA Grants Breakthrough Device Designation to Roche's Elecsys pTau217 Assay for Alzheimer's Diagnosis
2个月前
Roche to Present New Trontinemab Long-Term Data and PrevenTRON Phase III Trial Design at AAIC 2026
去年
Roche and Lilly's Alzheimer's Blood Test Receives FDA Breakthrough Device Designation
3个月前
Roche Secures CE Mark for Automated Elecsys IGRA TB Diagnostic Test
6个月前
ALZpath's pTau217 Antibody Gains Widespread Validation at AD/PD 2026 Conference
去年
Roche Launches Elecsys PRO-C3 Test for Precise Liver Fibrosis Assessment in MASLD Patients
5个月前
Roche Receives CE Mark for Elecsys NfL Blood Test to Monitor Multiple Sclerosis Neuroinflammation
去年
Acumen Pharmaceuticals' pTau217 Assay Streamlines Alzheimer's Clinical Trials
2个月前
Blood-Based Circular RNA Biomarkers Outperform pTau217 in Early Alzheimer's Detection, Landmark Nature Medicine Study Shows
去年
Acumen Pharmaceuticals Utilizes pTau217 Assay in Sabirnetug Phase 2 Alzheimer's Trial
第 1 页,共 5 页
上一页
下一页